Jazz Pharmaceuticals
Rylaze
Manufacturer:
Jazz Pharmaceuticals
Name:
Rylaze
HCPCS Code Descriptor:
Injection, asparaginase, recombinant, (rylaze), 0.1 mg
Category:
J Code
HCPCS:
J9021
NDC(s):
68727-0900-01, 68727-0900-03
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intramuscular
About:
Rylaze is an Oncology drug manufactured by Jazz Pharmaceuticals and administered via the Intramuscular route of administration. The J Code: J9021 is aligned to the drug Rylaze.